Investor Presentation Q1 2018

Investor Presentation First three months of 2018 Slide 112 Shaping and adapting to conditions in the business environment Enhancing access to affordable, high quality insulin is a key priority 5 million people with diabetes treated at cost below USD 0.16 per day 6 product recalls O failed inspections Cities Changing Diabetes works to bend the curve on urban diabetes UCL H Steno Diabetes Center Copenhagen C40 CITIES CLIMATE LEADERSHIP GROUP 103 million DKK donations to World Diabetes Foundation and Novo Nordisk Haemophilia Foundation 27.7 million patients reached with diabetes care products Note: Full social statements to be found in Novo Nordisk Annual Report 2017 changing diabetes • • novo nordisk Map the challenge in cities across the world with 11 cities enrolled Share learnings and best practices on how to bend the diabetes curve, by preventing rise in obesity Drive action plans with local partners and experts to act as a catalyst for meaningful action Initiate new cross-sector partnerships, eg on climate and health novo nordisk

View entire presentation